Thailand switches 2nd dose from Sinovac to AstraZeneca to combat Delta variant | Inquirer News

Thailand switches 2nd dose from Sinovac to AstraZeneca to combat Delta variant

/ 06:18 PM July 13, 2021

sinovac astrazeneca vaccines

Photo by The Nation/Asia News Network

BANGKOK — The Public Health Ministry of Thailand has switched its vaccine strategy from double doses of Sinovac to a combination of Sinovac and AstraZeneca jabs.

The move, announced on Monday by Public Health Minister Anutin Chanvirakul, comes after more than 600 medics were infected with Covid-19 despite having had both doses of Sinovac.

ADVERTISEMENT

The new strategy was approved by the National Communicable Disease Committee as a measure to combat the fast-spreading Delta variant which is becoming dominant in Thailand. It will be rolled out first

FEATURED STORIES

Under the strategy, a Sinovac jab will be administered first, followed by an AstraZeneca jab 3-4 weeks later. AstraZeneca is thought to offer more protection than Sinovac against the Delta strain.

Front-line health workers, most of whom have had two Sinovac jabs, will also get the AstraZeneca booster 3-4 weeks after their second Sinovac shot. Most doctors can now get the booster since more than four weeks have passed since their second dose.

Data indicates that mixing-and-matching vaccine doses boosts protection against Covid-19.

The Department of Disease Control reported on Sunday that 618 medical professionals had been infected by the virus since April despite having had their second Sinovac jab.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: AstraZeneca, Health, Sinovac, Thailand

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.